{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:30:08Z","timestamp":1784367008722,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1124\/jpet.122.001248","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T09:55:22Z","timestamp":1654854922000},"page":"113-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration"],"prefix":"10.1016","volume":"382","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-0797","authenticated-orcid":false,"given":"Thomas","family":"Boehm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Alix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Petroczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhii","family":"Vakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Gludovacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Borth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina A.","family":"Salminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001248_bib1","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.122.001248_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1254\/jjp.35.203","article-title":"Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments","volume":"35","author":"Aoyama","year":"1984","journal-title":"Jpn J Pharmacol"},{"key":"10.1124\/jpet.122.001248_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jth.14858","article-title":"Potential of heparin and nafamostat combination therapy for COVID-19","volume":"18","author":"Asakura","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1124\/jpet.122.001248_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1042\/bj1270875","article-title":"Oxidation of p-dimethylaminomethylbenzylamine by pig kidney diamine oxidase. A new method for spectrophotometric assay","volume":"127","author":"Bardsley","year":"1972","journal-title":"Biochem J"},{"key":"10.1124\/jpet.122.001248_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00011-020-01359-5","article-title":"Simple, sensitive and specific quantification of diamine oxidase activity in complex matrices using newly discovered fluorophores derived from natural substrates","volume":"69","author":"Boehm","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1124\/jpet.122.001248_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clinbiochem.2016.12.011","article-title":"Quantification of human diamine oxidase","volume":"50","author":"Boehm","year":"2017","journal-title":"Clin Biochem"},{"key":"10.1124\/jpet.122.001248_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/all.13663","article-title":"Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients","volume":"74","author":"Boehm","year":"2019","journal-title":"Allergy"},{"key":"10.1124\/jpet.122.001248_bib8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jaci.2021.03.043","article-title":"Metabolome and lipidome derangements during a severe mast cell activation event in a patient with indolent systemic mastocytosis","volume":"148","author":"Boehm","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.122.001248_bib9","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1111\/bph.14396","article-title":"Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome","volume":"175","author":"Ceuleers","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.122.001248_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1113\/jphysiol.1961.sp006669","article-title":"The simultaneous release of histamine and a histamine-destroving factor during anaphylaxis in rats","volume":"156","author":"Code","year":"1961","journal-title":"J Physiol"},{"key":"10.1124\/jpet.122.001248_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0016-5085(88)80069-6","article-title":"Postheparin plasma diamine oxidase in patients with small bowel Crohn\u2019s disease","volume":"95","author":"D\u2019Agostino","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.122.001248_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/0006-2952(84)90426-X","article-title":"Inhibitors of histamine metabolism in vitro and in vivo. Correlations with antitrypanosomal activity","volume":"33","author":"Duch","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.122.001248_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00775-001-0331-1","article-title":"Human kidney diamine oxidase: heterologous expression, purification, and characterization","volume":"7","author":"Elmore","year":"2002","journal-title":"J Biol Inorg Chem"},{"key":"10.1124\/jpet.122.001248_bib14","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/clinchem\/41.10.1522","article-title":"Composition of interstitial fluid","volume":"41","author":"Fogh-Andersen","year":"1995","journal-title":"Clin Chem"},{"key":"10.1124\/jpet.122.001248_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0005-2744(81)90023-1","article-title":"New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin","volume":"661","author":"Fujii","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.122.001248_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000492078","article-title":"A novel, nonpeptidic, orally active bivalent inhibitor of human \u03b2-tryptase","volume":"102","author":"Giardina","year":"2018","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.122.001248_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68542","article-title":"Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical","volume":"10","author":"Gludovacz","year":"2021","journal-title":"eLife"},{"key":"10.1124\/jpet.122.001248_bib18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3346\/jkms.2011.26.7.945","article-title":"Use of nafamostat mesilate as an anticoagulant during extracorporeal membrane oxygenation","volume":"26","author":"Han","year":"2011","journal-title":"J Korean Med Sci"},{"key":"10.1124\/jpet.122.001248_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1039\/D0SC05064D","article-title":"Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat","volume":"12","author":"Hempel","year":"2021","journal-title":"Chem Sci (Camb)"},{"key":"10.1124\/jpet.122.001248_bib20","first-page":"164","article-title":"Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system","volume":"15","author":"Hitomi","year":"1985","journal-title":"Haemostasis"},{"key":"10.1124\/jpet.122.001248_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00754-20","article-title":"Nafamostat mesylate blocks activation of SARS-CoV-2: New treatment option for COVID-19","volume":"64","author":"Hoffmann","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.122.001248_bib22","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1021\/bi00163a025","article-title":"Identification of topaquinone and its consensus sequence in copper amine oxidases","volume":"31","author":"Janes","year":"1992","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.122.001248_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0091-6749(82)80005-5","article-title":"Effects of infused histamine: correlation of plasma histamine levels and symptoms","volume":"69","author":"Kaliner","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.122.001248_bib24","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1021\/bi047440d","article-title":"Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase","volume":"44","author":"Khersonsky","year":"2005","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.122.001248_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.krcp.2015.10.003","article-title":"Cardiac arrest caused by nafamostat mesilate","volume":"35","author":"Kim","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"10.1124\/jpet.122.001248_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4168\/aair.2021.13.3.517","article-title":"Fatal anaphylaxis due to nafamostat mesylate during hemodialysis","volume":"13","author":"Kim","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1124\/jpet.122.001248_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jps.10534","article-title":"Transporter-mediated renal handling of nafamostat mesilate","volume":"93","author":"Li","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.122.001248_bib28","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000189371","article-title":"Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient","volume":"74","author":"Maruyama","year":"1996","journal-title":"Nephron"},{"key":"10.1124\/jpet.122.001248_bib29","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1021\/bi1010915","article-title":"Correlation of active site metal content in human diamine oxidase with trihydroxyphenylalanine quinone cofactor biogenesis","volume":"49","author":"McGrath","year":"2010","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.122.001248_bib30","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1021\/bi9014192","article-title":"Structure and inhibition of human diamine oxidase","volume":"48","author":"McGrath","year":"2009","journal-title":"Biochemistry"},{"key":"10.1124\/jpet.122.001248_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00498259409043223","article-title":"Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administration","volume":"24","author":"Midgley","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.122.001248_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12185-018-02567-w","article-title":"Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies","volume":"109","author":"Minakata","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1124\/jpet.122.001248_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.108.024083","article-title":"Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters","volume":"37","author":"Ming","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.122.001248_bib34","doi-asserted-by":"crossref","first-page":"M395","DOI":"10.1097\/00002480-199207000-00063","article-title":"Clinical evaluation of a new synthetic protease inhibitor in open heart surgery. Effect on plasma serotonin and histamine release and blood conservation","volume":"38","author":"Miyamoto","year":"1992","journal-title":"ASAIO J"},{"key":"10.1124\/jpet.122.001248_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1254\/jphs.92.420","article-title":"Nafamostat mesilate is an extremely potent inhibitor of human tryptase","volume":"92","author":"Mori","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.122.001248_bib36","first-page":"467","article-title":"Pharmacokinetic study of FUT-175 (nafamostat mesilate). (1) Blood level profiles, tissue distribution, metabolism and excretion in rats after intravenous administration","volume":"18","author":"Nanpo","year":"1984","journal-title":"Clin Rep"},{"key":"10.1124\/jpet.122.001248_bib37","doi-asserted-by":"crossref","first-page":"9921","DOI":"10.1016\/S0021-9258(17)36970-3","article-title":"Diamine oxidase is the amiloride-binding protein and is inhibited by amiloride analogues","volume":"269","author":"Novotny","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.122.001248_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1527-3466.1995.tb00213.x","article-title":"Nafamostat mesilate","volume":"13","author":"Okajima","year":"1995","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/jpet.122.001248_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-3565(25)38984-6","article-title":"Safety of high-dose of nafamostat mesilate: toxicological study in beagles","volume":"268","author":"Okamoto","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.122.001248_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/aor.13097","article-title":"Sustained deterioration of hepatic oxygenation after nafamostat mesilate-induced anaphylactic shock during hemodiafiltration","volume":"42","author":"Ookawara","year":"2018","journal-title":"Artif Organs"},{"key":"10.1124\/jpet.122.001248_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4009\/jsdt1985.24.49","article-title":"Pharmacokinetics of nafamostat mesilate (FUT) in patients undergoing hemodialysis [in Japanese]","volume":"24","author":"Osono","year":"1991","journal-title":"Dialysis J"},{"key":"10.1124\/jpet.122.001248_bib42","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/BF01716957","article-title":"Effects of histamine on the circulatory system","volume":"60","author":"Owen","year":"1982","journal-title":"Klin Wochenschr"},{"key":"10.1124\/jpet.122.001248_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0049-3848(91)90201-7","article-title":"Comparative study on the in vitro effectiveness of antithrombotic agents","volume":"64","author":"P\u00e2ques","year":"1991","journal-title":"Thromb Res"},{"key":"10.1124\/jpet.122.001248_bib44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01980899","article-title":"Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects","volume":"32","author":"Pollock","year":"1991","journal-title":"Agents Actions"},{"key":"10.1124\/jpet.122.001248_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3181\/00379727-79-19386","article-title":"Serum histaminase during rabbit anaphylaxis","volume":"79","author":"Rose","year":"1952","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1124\/jpet.122.001248_bib46","first-page":"261","article-title":"Clinical relevance of polyamines","volume":"18","author":"Russell","year":"1983","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1124\/jpet.122.001248_bib47","first-page":"744","article-title":"Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke","volume":"23","author":"Sakamoto","year":"2014","journal-title":"J Heart Valve Dis"},{"key":"10.1124\/jpet.122.001248_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1254\/jphs.09331SC","article-title":"Functional analysis of human organic cation transporter OCT2 (SLC22A3) polymorphisms","volume":"113","author":"Sakata","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.122.001248_bib49","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02142588","article-title":"Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO)","volume":"23","author":"Sattler","year":"1988","journal-title":"Agents Actions"},{"key":"10.1124\/jpet.122.001248_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1744-9987.12357","article-title":"Safety and tolerability of nafamostat mesilate and heparin as anticoagulants in leukocytapheresis for Ulcerative Colitis: Post hoc analysis of a large-scale, prospective, observational study","volume":"20","author":"Sawada","year":"2016","journal-title":"Ther Apher Dial"},{"key":"10.1124\/jpet.122.001248_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20050195","article-title":"Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels","volume":"202","author":"Schneider","year":"2005","journal-title":"J Exp Med"},{"key":"10.1124\/jpet.122.001248_bib52","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/s000110050273","article-title":"Analysis of tissue and subcellular localization of mammalian diamine oxidase by confocal laser scanning fluorescence microscopy","volume":"47","author":"Schwelberger","year":"1998","journal-title":"Inflamm Res"},{"key":"10.1124\/jpet.122.001248_bib53","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s000110050275","article-title":"Expression and cellular localisation of diamine oxidase in the gastrointestinal tract of pigs","volume":"47","author":"Schwelberger","year":"1998","journal-title":"Inflamm Res"},{"key":"10.1124\/jpet.122.001248_bib54","first-page":"319","article-title":"Potentiation by aminoguanidine of the sensitivity of sheep to histamine given by mouth. Effect of amino-guanidine on the urinary excretion of endogenous histamine","volume":"52","author":"Sjaastad","year":"1967","journal-title":"Q J Exp Physiol Cogn Med Sci"},{"key":"10.1124\/jpet.122.001248_bib55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-9378(64)90711-2","article-title":"Diamine oxidase in human pregnancy: plasma diamine oxidase in nonpregnant and normal pregnant patients","volume":"89","author":"Southren","year":"1964","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.122.001248_bib56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0091-6749(06)80017-5","article-title":"Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation","volume":"90","author":"van der Linden","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.122.001248_bib57","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1038\/s41598-018-24652-0","article-title":"Pregnancy-associated diamine oxidase originates from extravillous trophoblasts and is decreased in early-onset preeclampsia","volume":"8","author":"Velicky","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.122.001248_bib58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/mi.2017.121","article-title":"Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis","volume":"11","author":"Wechsler","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1124\/jpet.122.001248_bib59","doi-asserted-by":"crossref","first-page":"E629","DOI":"10.3390\/v12060629","article-title":"The anticoagulant nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner","volume":"12","author":"Yamamoto","year":"2020","journal-title":"Viruses"},{"key":"10.1124\/jpet.122.001248_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2133\/dmpk.21.147","article-title":"Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis","volume":"21","author":"Yamaori","year":"2006","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524003100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524003100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:03:49Z","timestamp":1743145429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524003100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0022356524003100"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001248","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}